State Street Corp Volitionrx LTD Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Volitionrx LTD stock. As of the latest transaction made, State Street Corp holds 123,923 shares of VNRX stock, worth $75,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,923
Previous 123,923
-0.0%
Holding current value
$75,593
Previous $89,000
5.62%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VNRX
# of Institutions
27Shares Held
7.96MCall Options Held
39KPut Options Held
0-
Lagoda Investment Management, L.P. New York, NY5.07MShares$3.09 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA636KShares$388,0610.0% of portfolio
-
Geode Capital Management, LLC Boston, MA617KShares$376,5930.0% of portfolio
-
Black Rock Inc. New York, NY574KShares$349,9930.0% of portfolio
-
Cowen Prime Advisors LLC179KShares$109,0300.09% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $35M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...